v3.20.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2020
Dec. 31, 2019
ASSETS    
Cash and cash equivalents $ 12,204,569 $ 16,350,237
Restricted cash 171,593 174,950
Short-term investments 10,983,190 11,984,157
Trade receivables 7,311 35
Inventories, net 294,908 338,465
Prepaid research and development expenses 37,507 34,831
Security deposit 20,000 20,000
Other prepaid expenses and current assets 3,561,972 446,415
Total current assets 27,281,050 29,349,090
Property and equipment, net 118,639 126,820
TOTAL ASSETS 27,399,689 29,475,910
LIABILITIES AND STOCKHOLDERS’ EQUITY    
Accounts payable 1,333,086 1,024,280
Accrued expenses 4,470,895 4,800,486
Deferred revenue 2,206
Total current liabilities 5,803,981 5,826,972
Operating lease liabilities, net of current portion 2,258 2,678
TOTAL LIABILITIES 5,806,239 5,829,650
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS’ EQUITY    
Preferred stock - $0.001 par value: 2,000,000 shares authorized; 241,623 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively 242 242
Common stock - $0.001 par value: 160,000,000 shares authorized; 26,127,067 and 25,665,350 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively 26,127 25,665
Accumulated other comprehensive income 90,736 97,257
Additional paid-in capital 222,455,084 218,944,268
Accumulated deficit (200,978,739) (195,421,172)
TOTAL STOCKHOLDERS’ EQUITY 21,593,450 23,646,260
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 27,399,689 $ 29,475,910